Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-30 @ 7:09 PM
Study NCT ID:
NCT03893656
Status:
COMPLETED
Last Update Posted:
2019-10-10
First Post:
2019-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retroperitoneoscopic Donor Nephrectomy
Sponsor:
Samsun Liv Hospital
Organization:
Study Overview
Official Title:
Retroperitoneoscopic Donor Nephrectomy: a Retrospective Single-center Study
Status:
COMPLETED
Status Verified Date:
2019-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RDN
Brief Summary:
to compare the results of right and left-sided retroperitoneoscopic donor nephrectomy (RDN).
Detailed Description:
This was a retrospective study evaluating demographics, intraoperative and postoperative data of 158 kidney donors who underwent RDN from January 2010 to August 2018. Two groups were created according to the side of the surgery including Right RDN (group 1) and left RDN (group 2). The results of the recipients' were also evaluated.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: